Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acquired | Acquired

About ITEA

Provider of energy recovery solutions. The company provides high-yield energy recovery technology suitable for residues from refinery, petrochemical, pharmaceutical, and other process industries. The company's solutions are based on hyperbaric sublimation technology and use air highly enriched with oxygen in order to achieve complete oxidation of materials in a reaction chamber and prevent the reformation of dioxins and furans. [Keywords: cleantech, energy/electricity generation]

ITEA Headquarters Location

Largo Buffoni 3



39 0331775910

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest ITEA News

Sopheon Wins European Research Award of Excellence

Nov 17, 2021

Sopheon developed a close integration of its Accolade® innovation system to Microsoft Azure Cloud Services for real-time sensor data interpretation and decision making November 17, 2021 09:00 AM Eastern Standard Time MINNEAPOLIS--( BUSINESS WIRE )-- Sopheon today announced that it participated in a joint research project that won the ITEA Award of Excellence. The project, PARTNER (Patient Care Advancement with Responsive Technologies and Engagement Together), offers solutions to support the optimal patient journey for chronic diseases through health systems. ITEA is the research, development, and innovation cluster of Eureka, an international network of large industry, subject matter experts, start-ups, academia, and customer organizations established in 1985 to encourage R&D cooperation. This ITEA project was coordinated by BARCO and had 20 participating partners, including Sopheon, from the academic and industrial world in the Netherlands, Belgium, Canada, and South Korea. Sopheon delivered a solution based on its Accolade innovation system with connection to Microsoft Azure Cloud Services. The solution automatically interprets massive data streams from vital sign sensors and other devices and generates meaningful notifications for the users. The Decision Support System (DSS) that Sopheon built contains a series of modules that ensure the interpretation algorithms are legally approved and the interpretation of data is private and secure. “Sopheon is proud of its contribution to this groundbreaking project and honored to have worked alongside industry leaders from around the world,” said Greg Coticchia, CEO of Sopheon. “Leveraging AI and machine learning to provide smart capabilities and predictive insights is vital for enhancing the innovation decision-making process. In this instance, Sopheon’s Accolade helped create a solution that is absolutely unique.” Enriched by experience with hundreds of long-standing, blue-chip customers, Sopheon provides the ability to control and manage innovation and new product development programs and pipelines more effectively and efficiently. Sopheon solutions deliver an innovation decision command center that gives companies complete visibility, smarter decision-making, and better time to value. To learn more about how Sopheon is transforming enterprise innovation, visit our website at . ABOUT SOPHEON Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Management solutions, including software, expertise, and best practices to achieve exceptional long-term revenue growth and profitability. Sopheon’s Accolade solution provides unique, fully integrated coverage for the entire innovation management and new product development life cycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management, and resource planning. Sopheon’s solutions have been implemented by over 250 customers with more than 60,000 users in over 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange. Sopheon and Accolade are trademarks of Sopheon plc. Contacts

  • When was ITEA founded?

    ITEA was founded in 1991.

  • What is ITEA's latest funding round?

    ITEA's latest funding round is Acquired.

  • Who are the investors of ITEA?

    Investors of ITEA include Banca di Roma and Banca Gesfid.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.